David Meiri Selected Research

Medical Marijuana

1/2022	The Effectiveness and Safety of Medical Cannabis for Treating Cancer Related Symptoms in Oncology Patients.
1/2022	Sex differences in medical cannabis-related adverse effects.
11/2021	Oral CBD-rich Cannabis Induces Clinical but Not Endoscopic Response in Patients with Crohn's Disease, a Randomised Controlled Trial.
1/2021	Medical Cannabis Use and Pain: An Experience Sampling Study.
1/2021	Medical cannabis and cognitive performance in middle to old adults treated for chronic pain.
1/2021	Medical cannabis treatment for chronic pain: Outcomes and prediction of response.
1/2021	Prolonged Medical Cannabis Treatment is Associated With Quality of Life Improvement and Reduction of Analgesic Medication Consumption in Chronic Pain Patients.
1/2021	Specific phytocannabinoid compositions are associated with analgesic response and adverse effects in chronic pain patients treated with medical cannabis.
12/2020	Medical cannabis and insomnia in older adults with chronic pain: a cross-sectional study.
11/2020	Short-Term Medical Cannabis Treatment Regimens Produced Beneficial Effects among Palliative Cancer Patients.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David Meiri Research Topics

Disease

6	Neoplasms (Cancer) 04/2022 - 03/2015
6	Chronic Pain 01/2021 - 12/2020
4	Pain (Aches) 01/2022 - 01/2021
1	Crohn Disease (Crohn's Disease) 11/2021
1	Cancer Pain 01/2021
1	Ulcerative Colitis 01/2021
1	Sleep Initiation and Maintenance Disorders (Insomnia) 12/2020
1	Migraine Disorders (Migraine) 06/2020
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2020
1	Carcinoma (Carcinomatosis) 01/2019
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019
1	Melanoma (Melanoma, Malignant) 01/2019

Drug/Important Bio-Agent (IBA)

12	Medical MarijuanaIBA 01/2022 - 01/2020
2	Dronabinol (THC)FDA LinkGeneric 01/2021 - 11/2020
2	Analgesics (Analgesic Drugs)IBA 01/2021 - 01/2021
1	EndocannabinoidsIBA 01/2021
1	Opioid Analgesics (Opioids)IBA 06/2020
1	Tryptamines (Triptans)IBA 06/2020
1	CannabinoidsIBA 01/2020
1	Terpenes (Terpenoids)IBA 01/2020
1	NivolumabIBA 01/2019
1	Monomeric GTP-Binding ProteinsIBA 03/2015
1	Cisplatin (Platino)FDA LinkGeneric 03/2015
1	Proteins (Proteins, Gene)FDA Link 03/2015
1	Platinum Compounds (Compounds, Platinum)IBA 03/2015

Therapy/Procedure

2	Immunotherapy 04/2022 - 08/2020
2	Therapeutics 08/2020 - 03/2015